Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort.
Soria A, Graziano F, Ghilardi G, Lapadula G, Gasperina DD, Benatti SV, Quiros-Roldan E, Milesi M, Bai F, Merli M, Minisci D, Franzetti M, Asperges E, Chiabrando F, Pocaterra D, Pandolfo A, Zanini F, Lombardi D, Cappelletti A, Rugova A, Borghesi ML, Squillace N, Pusterla L, Piconi S, Morelli P, Querini PR, Bruno R, Rusconi S, Casari S, Bandera A, Franzetti F, Travi G, D'Arminio Monforte A, Marchetti G, Pan A, Castelli F, Rizzi M, Dentali F, Mallardo M, Rossi E, Valsecchi MG, Galimberti S, Bonfanti P.
Soria A, et al. Among authors: lapadula g.
Heliyon. 2024 Aug 13;10(16):e36102. doi: 10.1016/j.heliyon.2024.e36102. eCollection 2024 Aug 30.
Heliyon. 2024.
PMID: 39247344
Free PMC article.